Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $35

Benzinga · 4d ago
Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $31 to $35.